ArticleJournal of diabetes and metabolic disorders2024
Managing high disease burden: a study of medication rationality in diabetes and hypertension in Andhra Pradesh.
Article in Journal of diabetes and metabolic disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To assess the burden of chronic Non-communicable diseases (NCDs) such as diabetes and hypertension, and evaluate the utilization of drugs for their treatment among the population of Andhra Pradesh, India. Methods: A cross-sectional study was conducted to analyse the prevalence of diabetes and hypertension, as well as the pattern of drug usage for their management. Data were collected through surveys and medical records review. Results: The study revealed a high prevalence of diabetes and hypertension in Andhra Pradesh, with significant proportions of the population remaining untreated despite critical drug utilization. Commonly used antidiabetic drugs included metformin, glipizide, and insulin, while telmisartan, furosemide, and metoprolol were frequently utilized for hypertension treatment. Side effects associated with these drugs were reported, emphasizing the need for better public awareness campaigns, improved access to healthcare, and effective management of side effects. Conclusions: The findings underscore the importance of early detection and preventive measures for hypertension and diabetes. There is a pressing need for tailored interventions addressing social and economic factors contributing to non-adherence to treatment regimens. While the widespread use of medications indicates significant awareness and proactive healthcare among a substantial portion of the population, the presence of individuals not adhering to their treatment suggests significant gaps in awareness and access to healthcare services. This study provides crucial insights into medication patterns for managing diabetes and hypertension in Andhra Pradesh, laying the groundwork for targeted public health interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.